Your figures divided by 10. that is my estimation but still...

First 4 Last

Share
Profile

Follow
wubing

4,109 Posts.

62

06/01/16

10:47

Post #: 16737540
Share

Originally posted by Smugtown ↑

I jumped in at 19c a few months ago on the back of some key points:

- Revenue increased from $12m in FY14 to $39.5m in FY15.
- 2nd half of FY15 was the first time we saw positive EBITDA - > $2M
- Letter of intent signed with Thales (they focus on defence, aerospace, airlines security and safety, information technology etc) coupled with increasingly unstable world geopolitics
- Managements ability to deliver on FY15 targets
- Order book of $130m and 1st qtr revenue of $12.7m
- Gross margin of -15% in FY14 based on $12m rev v GM of 30% in FY15 based on $39.5m. The increase in revenue between FY14 and FY15 was done at 50% GM. Anticipated 20% revenue growth in FY16 (looks very conservative to me).. suggests between $10m - $13m EBITDA for FY16 with massive growth predictions
- Cheap and quality carbon fibre components (increasing opportunity)
- Space exploration/technology to be back on the agenda over the next few years

Since then we have had

- a perhaps somewhat controversial discounted CR @ 13c for us and 15c for Deakin
- The strategic (and IMO fantastic) appointment of James Douglas who gives us the dual advantage of being involved in carbon fibre and investment banking.
- Lockheed Martin awarded 32 more aircraft
- First delivery of JSF tails expected in Q4 of FY16
- Ability to plan and execute for growth and scale with QURE (only downside is may involve another CR in 9-12 months to deal with scale - however is scale contracts signed, then good result)
- Warn Ponds R&D facility fit out getting closer to completion
- Dent reduction from CR
- Increased broker coverage

This business has a market cap of $80m. If the FY16 EBITDA between $10m-$13m holds true, i's suggest we are looking very undervalued with our order book and best of breed technology and recent R&D centre.

I'd like to see 20c by mid-year and pushing 30c within a year. From there we may need an additional CR to cope with scale, which as i mentioned can only be a good thing, and if it can be done at a significant premium to this last CR, this is crucial. If done under 20c, then, ouch.

Conclusion - it is all moving forward and looking good...patience is the key. 3 year outlook... maybe 80c - $1.

Expand

Your figures divided by 10. that is my estimation but still fabulous! isn't it?

ALT Price at posting: 0.6¢ Sentiment: Buy Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

ACW

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

Breaking news: New opportunities for investors & companies - HotCopper opens to capital raising!

First 4 Last

Add ALT (ASX) to my watchlist

Your figures divided by 10. that is my estimation but still...

Top Stories

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

Breaking news: New opportunities for investors & companies - HotCopper opens to capital raising!

Featured News